financetom
Business
financetom
/
Business
/
Compass Pathways Insider Sold Shares Worth $461,332, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Compass Pathways Insider Sold Shares Worth $461,332, According to a Recent SEC Filing
Apr 2, 2024 1:42 PM

04:27 PM EDT, 04/02/2024 (MT Newswires) -- George Jay Goldsmith, 10% Owner, on April 01, 2024, sold 51,500 shares in Compass Pathways ( CMPS ) for $461,332. Following the Form 4 filing with the SEC, Goldsmith has control over a total of 8,018,534 shares of the company, with 4,010,404 shares held directly and 4,008,130 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1816590/000181659024000064/xslF345X03/wk-form4_1712089398.xml

Price: 9.23, Change: -0.22, Percent Change: -2.33

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
GSK shares fall after blood cancer drug likely headed for U.S. rejection
GSK shares fall after blood cancer drug likely headed for U.S. rejection
Jul 18, 2025
(Reuters) -GSK shares fell more than 6% on Friday after a U.S. FDA advisory panel recommended against approving its blood cancer drug Blenrep, citing earlier concerns over eye-related side effects. The British drugmaker was trying to revive the drug, which was pulled from U.S. markets in 2022 after failing a late-stage study. GSK's renewed application is based on two late-stage...
BRIEF-David Rhodes Is In Talks To Take Over CBS News If The Skydance Acquisition Of Paramount Closes - Puck News
BRIEF-David Rhodes Is In Talks To Take Over CBS News If The Skydance Acquisition Of Paramount Closes - Puck News
Jul 18, 2025
July 18 (Reuters) - * DAVID RHODES IS IN TALKS TO TAKE OVER CBS NEWS IF THE SKYDANCE ACQUISITION OF PARAMOUNT CLOSES - PUCK NEWS Source text: https://tinyurl.com/mr3787mt Further company coverage: ...
David Rhodes in talks to take over CBS after Paramount-Skydance deal closes, Puck News said
David Rhodes in talks to take over CBS after Paramount-Skydance deal closes, Puck News said
Jul 18, 2025
July 18 (Reuters) - David Rhodes, the former CBS News head and Sky executive, is in talks to take over CBS News if the Skydance acquisition of Paramount closes, US-based digital news website Puck news said on Thursday. CBS parent Paramount Global ( PARAA ) is seeking approval from the U.S. Federal Communications Commission for an $8.4-billion merger with Skydance...
Copyright 2023-2026 - www.financetom.com All Rights Reserved